Boosterix vaccine Use -: Diphtheria, tetanus and pertussis booster vaccination in adults, children greater than or equal to 10 years. It could be expected that immunisation of immediate close contacts of newborn infants, such as parents, grandparents and healthcare workers, would reduce exposure of pertussis to infants not yet adequately protected through immunisation. Dosage - 0.5 mL deep IMI according to accepted immunisation schedule Side-effects - Local reaction; fever, malaise; headache, dizziness (similar profile to Infanrix) Reference Product information 28/07/2000
|
|
|